Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions

Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions

US Patent 6255281 · Granted Jul 3, 2001

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method, apparatus, and system for obtaining network slice2022
Compositions and methods of use for recombinant human secretoglobins2022
Method, apparatus, and system for obtaining network slice2022
Wolfram carbide based hard alloy and its preparation method2021
Compositions and methods of use for recombinant human secretoglobins2020
Method, device, and system for quickly informing CGN exception2018
Compositions and methods of use for recombinant human secretoglobins2017
IGMP/MLD translation2017
Small molecule therapeutic compounds targeting thioesterase deficiency disorders2017
Small molecule therapeutic compounds targeting thioesterase deficiency disorders2017
Method for determining multicast path, method for receiving data packet, and rou2017
Method, device, and system for quickly informing CGN exception2017